Medi-CapsBOM:523144 -1.07%47 Forward Dividend Yield % is 0.00% as of Jul. 09, 2026. GuruFocus rates BOM:523144 with a GF Score™ of 47/100 and a GF Value™ of ₹20.04 (Modestly Overvalued). The stock has 4 warning signs investors should review. Among 856 Real Estate companies, Medi-Caps ranks worse than 116822.31% on this metric.
As of today (2026-07-09), the Forward Annual Dividend Yield of Medi-Caps is 0.00%.
As of today (2026-07-09), the Trailing Annual Dividend Yield of Medi-Caps is 0.00%.
BOM:523144's Forward Dividend Yield % is not ranked *
in the Real Estate industry.
Industry Median: 3.585 * Ranked among companies with meaningful Forward Dividend Yield % only.
Over the long term, the return from dividends has been a significant contributor to the total returns produced by equity securities. Studies by Elroy Dimson, Paul Marsh, and Mike Staunton of Princeton University (2002) found that a market-oriented portfolio, which included reinvested dividends, would have generated nearly 85 times the wealth generated by the same portfolio relying solely on capital gains.
Dividends may also qualify a lower tax rate for investors.
In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.
For the Real Estate - Diversified subindustry, Medi-Caps's Forward Dividend Yield %, along with its competitors' market caps and Forward Dividend Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Medi-Caps Forward Dividend Yield % vs Real Estate Industry
For the Real Estate industry and Real Estate sector, Medi-Caps's Forward Dividend Yield % distribution charts can be found below:
* The bar in red indicates where Medi-Caps's Forward Dividend Yield % falls into.
What does a Forward Dividend Yield % of 0.00% mean?
Medi-Caps (BOM:523144) has a Forward Dividend Yield % of 0.00% as of Jul. 09, 2026. Forward dividend yield is the ratio of company's expected dividends to the share price. View historical data on Medi-Caps and its competitors. According to the industry distribution chart, Medi-Caps ranks #999999 out of 856 companies in the Real Estate industry.
Is Medi-Caps' Forward Dividend Yield % too high?
Medi-Caps' current Forward Dividend Yield % is 0.00%. Based on the distribution chart, Medi-Caps ranks #999999 out of 856 companies in the Real Estate industry, which is in the bottom quartile relative to peers. Overall, Medi-Caps has a GF Score™ of 47/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Medi-Caps' Forward Dividend Yield % compare to competitors?
According to the Real Estate industry distribution chart, Medi-Caps ranks #999999 out of 856 companies for Forward Dividend Yield %. This places Medi-Caps in the lower half of its industry. The industry median Forward Dividend Yield % is 3.59. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Forward Dividend Yield % for a Real Estate company?
The median Forward Dividend Yield % among Real Estate companies is 3.59, based on 856 companies in the industry. Companies in the top quartile (top 25%) have a Forward Dividend Yield % significantly above this median, while those in the bottom quartile fall well below. However, Forward Dividend Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Forward Dividend Yield % mean?
A high Forward Dividend Yield % can signal that a stock is expensive relative to its fundamentals. Forward dividend yield is the ratio of company's expected dividends to the share price. View historical data on Medi-Caps and its competitors. For the Real Estate industry, the median Forward Dividend Yield % is 3.59 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Medi-Caps's current Forward Dividend Yield % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medi-Caps stock overvalued right now?
Based on GuruFocus' analysis, Medi-Caps (BOM:523144) is currently considered Modestly Overvalued. The stock's GF Value™ is ₹20.04, compared to a current price of ₹25.98 — trading 29.6% above its estimated fair value. The current Forward Dividend Yield % is 0.00%. Medi-Caps' overall GF Score™ is 47/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Forward Dividend Yield % calculated?
Forward Dividend Yield % is calculated from a company's financial statements. For Medi-Caps (BOM:523144), the current Forward Dividend Yield % is 0.00% as of Jul. 09, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Medi-Caps (BOM:523144) Overvalued in 2026?
Based on GuruFocus' analysis, Medi-Caps stock appears to be overvalued.
The current stock price of ₹25.98 is trading 29.6% above its estimated GF Value™ of ₹20.04.
GuruFocus considers Medi-Caps to be Modestly Overvalued.
Key valuation signals for BOM:523144:
Forward Dividend Yield %: 0.00%
GF Value™: ₹20.04 vs. price of ₹25.98 (29.6% above fair value)
No single metric tells the full story. See the BOM:523144 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Medi-Caps Ltd is an India-based company engaged in the real estate business witch city centric developments by way of Strategic Land acquisition and developing the residential and commercial properties. Its project include Medicaps Business Park. The group has two segments namely, the Pharma Division, and the Real Estate Division. The majority of its revenue is generated from the Pharma Division.
47GF Score
Get the complete analysis for BOM:523144
Forward Dividend Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:523144 has been successfully added to your 